Using Carbon Quantum Dots to prevent neurodegeneration caused by pesticides
Development and testing of Carbon Quantum Dot architectures to arrest neurotoxicant-insult- related outcomes
This study is looking at how tiny particles called Carbon Quantum Dots, made from natural substances, might help protect nerve cells from damage caused by pesticides and other harmful chemicals, and it's for anyone interested in keeping their brain healthy in the face of these dangers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas El Paso NIH-funded |
| Lab location | 1 site (El Paso, United States) |
| Project ID | NIH-11100876 on NIH RePORTER |
What this research studies
This research investigates how Carbon Quantum Dots (CQDs), derived from organic acids, can help protect neurons from damage caused by exposure to pesticides and other neurotoxic substances. The study explores the mechanisms by which CQDs can prevent the transformation of harmful proteins and reduce oxidative stress in neuronal cells. By testing these CQDs in both laboratory settings and animal models, the research aims to identify their effectiveness in preserving neuronal health and function in the context of pesticide exposure.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of pesticide exposure or those at risk for neurodegenerative diseases such as Alzheimer's.
Not a fit: Patients who have no history of pesticide exposure or neurodegenerative conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing neurodegenerative diseases linked to pesticide exposure.
How similar studies have performed: While the use of Carbon Quantum Dots in neuroprotection is a novel approach, preliminary data suggests potential success in similar applications.
Where this research is happening
El Paso, United States
- University of Texas El Paso — El Paso, United States (Active)
Researchers
- Principal investigator: Narayan, Mahesh — University of Texas El Paso
- Study coordinator: Narayan, Mahesh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.